⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RANI News
Rani Therapeutics Holdings, Inc. Class A Common Stock
Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing
globenewswire.com
RANI
Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules
globenewswire.com
RANI